SCHEMBL2777031

SCHEMBL2777031

CN(c1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CC(C)(C)CC4)CC3)cc2Oc2cc(NC(=O)O)nc(NC(=O)O)c2)cc1[N+](=O)[O-])C1CCOCC1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 19/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957379 0.96 BCL2 (0.80) BCL2
SCHEMBL2481508 0.90 BCL2 (0.73) BCL2
SCHEMBL2777043 0.90 BCL2 (0.88) BCL2
SCHEMBL15991888 0.89 BCL2 (0.82) BCL2
SCHEMBL3496249 0.88 BCL2 (0.75) BCL2
SCHEMBL2480390 0.88 BCL2 (0.75) BCL2
SCHEMBL1957674 0.88 BCL2 (0.83) BCL2
SCHEMBL1957091 0.88 BCL2 (0.82) BCL2
SCHEMBL23165076 0.87 BCL2 (0.64) BCL2
SCHEMBL2774580 0.87 BCL2 (0.89) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010065824-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-06-10 — — WO disclosed
Send feedback